Proov, the creator of a suite of at-home fertility-related hormone tests, has announced today that an equity share of the company has been purchased by GRAMMY award-winning singer-songwriter, actor and author Ashanti and her fiancé, GRAMMY winning, Double Diamond selling, entertainment icon Nelly. This news
comes off of the duo’s pregnancy announcement via Instagram last week, which featured the Proov Check test.
Proov CEO Dr. Amy Beckley shares: “The team and I are thrilled to have Ashanti and Nelly join us in our mission to increase visibility and accessibility of clinically proven fertility and pregnancy related solutions to those who need them.”
Ashanti and Nelly echo: “We’re excited to work together on our first joint business endeavor, championing a female-led enterprise dedicated to empowering women with personalized care solutions.”
Proov is a diagnostics company offering medical grade at-home tests and a support platform
that is clinically proven to help those looking to conceive do so faster, and more cost-effectively.
Proov goes beyond typical fertility tracking (which focuses on finding the fertile window) to help
uncover key issues that can make conceiving more difficult. Proov founder, Dr. Amy Beckley,
PhD, created the core Proov technology (Proov Confirm PdG tests) after her own battle with
infertility.
Today Proov offers over 10 products. The latest addition to the Proov portfolio is Proov Path to Pregnancy, an at-home fertility treatment program offering a less invasive and more affordable option compared to traditional in-vitro fertilization (IVF).
